Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 2Phase EARLY_PHASE1 1Phase 1 1

Status

Terminated 3Completed 3Recruiting 2

Sponsor Class

OTHER 8INDUSTRY 6

Study Type

Interventional 7Observational 1

Sponsor

Cancer Type

Breast 85Gastrointestinal 13CNS 9Tumor-Agnostic 8Genitourinary 7Other solid neoplasm 6Gynecologic 6Thoracic 4Head & Neck 4Endocrine 1

Conditions

Neoplasm Metastasis 5Neoplasms 2Carcinoma, Squamous Cell 1

Interventions

Surveys and Questionnaires 70Blood Specimen Collection 48Radiotherapy 39Magnetic Resonance Spectroscopy 35pembrolizumab 31Gemcitabine 30Bevacizumab 30Nivolumab 29Carboplatin 29Radiosurgery 27Standard of Care 26Oxaliplatin 26Capecitabine 25Paclitaxel 24Interviews as Topic 24Cisplatin 24Fluorouracil 23Erlotinib Hydrochloride 22Everolimus 19Irinotecan 18Trastuzumab 17Methods 17Exercise 17Docetaxel 17Biopsy 17Cyclophosphamide 16Educational Status 15Sorafenib 14Ipilimumab 14Fluorodeoxyglucose F18 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
OTHER × Lapatinib × Tumor-Agnostic × Clear all
NCT02029001 2025-08-07

MOST plus

Centre Leon Berard

Phase 2 Recruiting
900 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT05467189 2022-07-20

Antineoplastic Drugs in Elderly Patients

Shandong University

Recruiting
500 enrolled
Tumor-Agnostic

Neoplasms

NCT01636908 2021-04-15

ICK

Amsterdam UMC, location VUmc

Phase NA Completed
43 enrolled
Tumor-Agnostic

Neoplasms

NCT01190241 2020-11-20

TSAP

Amsterdam UMC, location VUmc

Phase NA Terminated
45 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT02142036 2019-03-13

MetAction

Oslo University Hospital

Phase 2 Completed
50 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT01087983 2015-11-11

Lapatinib With Sirolimus or Metformin

M.D. Anderson Cancer Center

Phase 1 Completed
111 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT01427322 2015-07-08

Randomized RT +/- Lapatinib for Advanced Solid Tumor Cancer Patients Receiving Radiation Therapy for Metastatic Disease

Virginia Commonwealth University

Phase EARLY_PHASE1 Terminated
6 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT01666431 2014-12-03

Single-center Investigator Initiated Pilot Study Investigating the Tumor Response of Squamous Cell Carcinoma Lesions in Patients Under Lapatinib Treatment

University of Zurich

Phase 2 Terminated
10 enrolled
Tumor-Agnostic

Carcinoma, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡